Cerus CERS
NASDAQ CERS
$2.78 -0.07 (-2.46%)
As of: Aug 20, 2026 · 3:59 PM EDT

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026)

Cerus (CERS) posted Liabilities and Shareholders Equity of $205.2 million for Q2 2026, down 7.95% sequentially from $222.9 million in Q1 2026, and down 3.7% YoY from $213.1 million in Q2 2025.

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Cerus has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $205.2 million in Q2 2026.

  • Quarterly Liabilities and Shareholders Equity fell 3.7% year-over-year to $205.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $865.1 million (up 6.77% YoY) and the FY2025 annual result came in at $221.9 million, up 10.42% from the prior year.
  • Liabilities and Shareholders Equity eased to $205.2 million in Q2 2026 per CERS's latest filing, from $222.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $222.9 million in Q1 2026 and troughed at $185.5 million in Q2 2024.
  • A 5-year average of $207.4 million and a median of $208.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity dropped 9.65% in 2024, then grew 14.87% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $218.1 million in 2022, then slipped by 9.33% to $197.7 million in 2023, then grew by 1.6% to $200.9 million in 2024, then advanced by 10.42% to $221.9 million in 2025, then retreated by 7.51% to $205.2 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $205.2 million, $222.9 million, and $221.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Cerus 560.58 Mn 504.32 Mn 29.53 Mn 205.19 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 205.19 Mn
Mar 31, 2026 222.91 Mn
Dec 31, 2025 221.86 Mn
Sep 30, 2025 215.19 Mn
Jun 30, 2025 213.07 Mn
Mar 31, 2025 206.78 Mn
Dec 31, 2024 200.92 Mn
Sep 30, 2024 189.54 Mn
Jun 30, 2024 185.50 Mn
Mar 31, 2024 189.14 Mn
Dec 31, 2023 197.75 Mn
Sep 30, 2023 205.84 Mn
Jun 30, 2023 198.86 Mn
Mar 31, 2023 209.34 Mn
Dec 31, 2022 218.09 Mn
Sep 30, 2022 215.40 Mn
Jun 30, 2022 216.46 Mn
Mar 31, 2022 221.91 Mn
Dec 31, 2021 237.50 Mn
Sep 30, 2021 218.95 Mn